Zoekresultaten - 27 results

Severity of infection with the SARS-CoV-2 B.1.1.7 lineage among hospitalized COVID-19 patients in Belgium.

framework to study the severity of SARS-CoV-2 variants by merging surveillance registries in Belgium. Infection with SARS-CoV-2 B.1.1.7 (‘exposed’) was compared to infection with previously circulating ...

The non-fatal burden of cancer in Belgium, 2004–2019: a nationwide registry-based study

Devleesschauwer; Niko Speybroeck Source: BMC Cancer, Volume 22, Issue 1 (2022) Keywords: burden of disease Cancer epidemiology Disability-Adjusted Life Years Years lived with disability Abstract: Background The ...

Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future

Publication Type: Peer reviewed scientific article Authors: T. Geukens; M. Brandão; A. Laenen; J. Collignon; C. Van Marcke; I. Louviaux; W. Demey; S. Van Wambeke; D. Schrijvers; S. Lecomte; J. Mebis; A. Rutten; C. Fontaine; W. Lybaert; S. Aspeslagh; J.-C. ...

Conducting national burden of disease studies in small countries in Europe– a feasible challenge?

expertise, and engage with countries and institutions that have long-standing experience with BoD assessment. Conclusion Apart from mortality registries, adequate health data sources, notably for cancer, are ...

The EMPCAN study: protocol of a population-based cohort study on the evolution of the socio-economic position of workers with cancer

socio-professional support. Methods: We requested data from the Belgian Cancer Registry and the Crossroad Bank for Social Security. We included all socially insured Belgian workers diagnosed between 2004 and 2011 with ...

Cervical morbidity in Alsace, France: results from a regional organized cervical cancer screening program.

Volume 28, Issue 1 (2019) Keywords: Adult Early Detection of Cancer Female France Humans middle aged morbidity Papillomavirus Vaccines REGISTRIES Uterine Cervical Neoplasms Abstract: In 1994, a pilot ...

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.

causally linked with the development of cervical precancer and cancer. HPV types 16 and 18 cause approximately 70% of cervical cancers worldwide. OBJECTIVES: To evaluate the harms and protection of ...

VALGENT: A protocol for clinical validation of human papillomavirus assays.

Detection of Cancer Female Genotyping Techniques Human Papillomavirus DNA Tests Humans Mass Screening middle aged Papillomaviridae Papillomavirus Infections Reagent Kits, Diagnostic Uterine Cervical Neoplasms ...

Melanoma burden by melanoma stage: Assessment through a disease transition model

The model was applied to a large cohort of 8016 melanoma patients recorded by the Belgian Cancer Registry for incidence years 2009-2011. DALY s were calculated for each American Joint Committee on ...

QR code

QR code for this page URL